Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 57Lymphoma, Large B-Cell, Diffuse 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Follicular 33Leukemia 30Lymphoma, Non-Hodgkin 28Burkitt Lymphoma 19Hodgkin Disease 18Neuroblastoma 13Lymphoma, Large-Cell, Immunoblastic 12Central Nervous System Neoplasms 12Sarcoma 10Multiple Myeloma 10Lymphoma, Mantle-Cell 10Rhabdomyosarcoma 9Wilms Tumor 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, B-Cell, Marginal Zone 7Oligodendroglioma 6Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasms, Plasma Cell 5Neoplasms 5Malignant mesenchymal tumor 5Leukemia, Lymphocytic, Chronic, B-Cell 5Brain Neoplasms 5Astrocytoma 5Retinoblastoma 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Radiotherapy 2Paclitaxel 2Fluorouracil 2Etoposide 2Carboplatin 2etoposide phosphate 1Vincristine 1Porfiromycin 1Mitomycin 1Leucovorin 1Irinotecan 1Gemcitabine 1Epirubicin 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Brachytherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Unknown Primary × Vincristine × Clear all
NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡